neuropeptide af (human)

Neuropeptide AF (93-110), Human is an endogenous antiopioid peptide.

Neuropeptide AF (human) acetate (Neuropeptide AF (human) acetate (192387-38-5 Free base)) 属于抗阿片类神经肽，是 Neuropeptide AF (human) 衍生物，可调节脂肪细胞代谢。

Neuropeptide SF (human) aceate 是一种神经肽，可增强心室旁 CRH 的释放并增加血浆中的 ACTH 和皮质酮水平。

Neuropeptide Y (29-64), amide, human acetate 参与阿尔茨海默病 (AD) 并保护大鼠皮质神经元免受 β-淀粉样蛋白毒性。

Neuropeptide W-23(human) (NPW-23) 是 NPBW1 和 NPBW2 的内源性配体，是 Neuropeptide W 的主要活性形式。

'(Des-Bromo)-Neuropeptide B (1-23) (human)' 是一种作用于orphan G-protein coupled receptor的激动剂，对GPR7 (NPBW1) 的Ki值为1.2 nM，而对GPR8 (NPBW2) 的Ki值则为341 nM。

Neuropeptide Y (1-24) (human) 是一种神经肽，它能够抑制大鼠输精管电刺激引发的抽搐反应，同时在体内刺激 N-methyl-D-aspartate (NMDA) 促使大鼠海马背侧 CA3 区神经元激活。

[D-Arg25]-Neuropeptide Y (human) ([D-Arg25] NPY) 是Y1受体的选择性激动剂。与阿尔茨海默病相关，该化合物能够保护老鼠皮质神经元免受淀粉样蛋白毒性的损害。

Neuropeptide Y (NPY) (3-36) is a C-terminal fragment of NPY, a neuropeptide involved in controlling appetite, blood pressure, cardiac contractility, and intestinal secretion. NPY (3-36) is an endogenous peptide produced by cleavage of NPY by dipeptidyl peptidase 4 (DPP-4). It binds selectively to the NPY receptor Y2 (Ki = 0.41 nM in CHP 234 cells) over the Y1 receptor, where it does not bind at concentrations up to 1 μM. NPY (3-36) (0.1 nM) increases migration of human umbilical vein endothelial cells (HUVECs) by 80% after 12 hours in an in vitro wound closure assay. NPY (3-36) corresponds to residues 3-36 of the human and rat protein sequence.

Neuropeptide Y (13-36), amide, human is a neuropeptide Y receptor agonist.

Biotinyl-neuropeptide W-23 (human)为生物素化neuropeptide W-23 (human)的衍生物，该化合物作为NPBW1 (GPR7)和NPBW2 (GPR8)的激动剂。

Neuropeptide Y (3-36) (human, rat) is a metabolite of neuropeptide Y (NPY) generated by dipeptidyl peptidase-4 (DPP4). Known as a selective Y2 receptor agonist, Neuropeptide Y (3-36) (human, rat) effectively reduces the release of norepinephrine via the Y2 receptor[1][2].

Neuropeptide Y (29-64), amide, human is a biologically active 36-amino acid peptide.

Neuropeptide S human (TFA) is a potent endogenous neuropeptide S receptor agonist (EC50=9.4 nM).

[Leu31,Pro34]-Neuropeptide Y(human,rat) TFA 是一种针对神经肽 YY1受体的特定激动剂，并亦能够激活Y4和Y5受体。该化合物能提高麻醉大鼠的血压并增加食物摄入。

Neuropeptide AF (cattle)是一种RFamide家族的酰胺化十八肽，主要作用于Mas相关基因受体A4 (MrgprA4) (Mas-related G-protein-coupled Receptor (MRGPR))和MrgprC11，其EC50分别约为60 nM和300 nM。此外，该化合物还能激活G蛋白偶联受体NPFF1 (Neuropeptide Y Receptor) 和NPFF2，EC50范围分别为25-325 nM和1-5 nM。Neuropeptide AF (cattle)具有显著的抗阿片及疼痛调节功能。

Neuropeptide W-23 (human) (NPW-23) TFA 作为Neuropeptide W的优势活性形态，充当NPBW1（GPR7）与NPBW2（GPR8）的内源性激动剂。

Neuropeptide Y (29-64), amide, human (TFA) is involved in Alzheimer's disease (AD) and protects rat cortical neurons against β-Amyloid toxicity.It is showed that Neuropeptide Y (29-64), amide, human (TFA) is able to protect cortical neurons from Aβ25-35 t

Neuropeptide Y (human) TFA, a compound implicated in Alzheimer's disease (AD), exhibits protective effects against β-Amyloid toxicity in rat cortical neurons.

Neuropeptide SF (human) 显着增加异源表达 ASIC3 的持续电流幅度（FMRFamide 和 NPFF 分别为 12 倍和 19 倍和 9 倍），EC50 约为 50 μM。

High affinity neuropeptide Y Y1 receptor agonist (Ki = 0.39 nM). Also shows affinity for Y4 and Y5 receptors.

Potent endogenous neuropeptide S receptor agonist (EC50 = 9.4 nM). Increases locomotor activity and wakefulness in mice. Also reduces anxiety-like behavior in mice.